New Data on HIV Prevention

In 2006, Gilead scientists began work on a potential long-acting HIV medication. After more than a decade of preclinical development and clinical trials, we’ve now announced topline results from a study investigating its use for HIV prevention.

Our Purpose

A group of people sitting at a table

We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.

Our Mission

Recent Stories

Eyepiece of a microscope

Join Our Team

We're Hiring